New research suggests that a protein the body relies on to manage appetite and energy levels cannot function on its own. Instead, it depends on a partner protein to work properly. This discovery could help scientists better understand how genetic…
Category: 8. Health
-

Certain Plant-Based Diets Raise Heart Disease Risk
New research published in The Lancet Regional Health – Europe suggests that certain types of plant-based diets, particularly plant-based diets that rely heavily on ultra-processed foods, may increase the risk…
Continue Reading
-

The Silver Lining in Disappointment
Explore
Disappointment stings. But this feeling may be more useful than you might think….
Continue Reading
-

Polar plunges aren’t just for the daring
On January 1, some hardy souls will greet the new year not by nursing a champagne hangover in bed, but by plunging into frigid water. In New York City, thousands of people participate in a seaside “polar plunge” held annually since…
Continue Reading
-

Integrated quality control processes for cell therapy workflows
Unlock App Note ALREADY ACCESSED THIS App Note?
SIGN INCAR-T cell therapy research for B cell cancers must meet FDA guidelines for safety,…
Continue Reading
-

Advancing Personalized Cancer Therapies | Cancer
Please fill out this field.
Please fill out this field.…
Continue Reading
-

Advancing Personalized Cancer Therapies | Cancer
Please fill out this field.
Please fill out this field.…
Continue Reading
-

Advancing Personalized Cancer Therapies | Cancer
Please fill out this field.
Please fill out this field.…
Continue Reading
-

Dual PI3K/mTOR inhibition is required to combat resistance to CDK4/6 inhibitor and endocrine therapy in PIK3CA-mutant breast cancer | Science Translational Medicine
Gedatolisib is more effective than alpelisib in preclinical models of PIK3CA-mutant ER+ advanced breast cancer.
Continue Reading
-

Single–amino acid variants in target epitopes can confer resistance to antibody-based therapies | Science Translational Medicine
Naturally occurring genetic variants in genes encoding human target antigens can confer resistance to antibody-based therapies.
Continue Reading

